| 000 | 01261 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250517201409.0 | ||
| 264 | 0 | _c20181211 | |
| 008 | 201812s 0 0 eng d | ||
| 022 | _a1744-7631 | ||
| 024 | 7 |
_a10.1080/14728222.2018.1439922 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMünzel, Thomas | |
| 245 | 0 | 0 |
_aThe potential of aldehyde dehydrogenase 2 as a therapeutic target in cardiovascular disease. _h[electronic resource] |
| 260 |
_bExpert opinion on therapeutic targets _c03 2018 |
||
| 300 |
_a217-231 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAldehyde Dehydrogenase, Mitochondrial _xdrug effects |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntioxidants _xmetabolism |
| 650 | 0 | 4 |
_aCardiovascular Agents _xpharmacology |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xdrug therapy |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 700 | 1 | _aDaiber, Andreas | |
| 773 | 0 |
_tExpert opinion on therapeutic targets _gvol. 22 _gno. 3 _gp. 217-231 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/14728222.2018.1439922 _zAvailable from publisher's website |
| 999 |
_c28073757 _d28073757 |
||